NCT06495008View on ClinicalTrials.gov

Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

February 11, 2025

Study Completion Date

February 11, 2025

Conditions
MelanomaNon-small Cell Lung Cancer (NSCLC)Urogenital Cancers
Interventions
OTHER

no intervention, only questionnaires, saliva collection and taste/smell tests

no intervention, only questionnaires, saliva collection and taste/smell tests

Trial Locations (1)

9713 GZ

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT06495008 - Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy | Biotech Hunter | Biotech Hunter